IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.

Andere talen Immuno-Biological Laboratories Co., Ltd.

Aandelen

4570

JP3921300004

Vertraagde tijd Japan Exchange Andere beurzen 05:38:20 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
503 ^JPY	-0,20%		0,00%	+2,03%

2023

Immuno-Biological Laboratories Co. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 maart 2023

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	12-05-23
An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd.	06-02-23
An undisclosed buyer acquired 26.32% stake in Cell Remover Co., Ltd. from Immuno-Biological Laboratories Co., Ltd..	20-12-19
CURED Co., Ltd. announced that it has received ¥598.4 million in funding from Immuno-Biological Laboratories Co., Ltd.	29-03-19
CURED Co., Ltd. announced that it expects to receive ¥598.4 million in funding from Immuno-Biological Laboratories Co., Ltd.	27-02-19
Neo Silk Cosmetics Co., Ltd. announced that it has received ¥40 million in funding from Immuno-Biological Laboratories Co., Ltd.	15-11-18
Neo Silk Cosmetics Co., Ltd announced that it expects to receive ¥40 million in funding from Immuno-Biological Laboratories Co., Ltd.	05-11-18
Transgenic Inc. Enters into Joint Research Agreement with Immuno-Biological Laboratories Co. Ltd	28-06-17
Immuno-Biological Laboratories Co., Ltd. announced that it has received ¥1.4 billion in funding from Whiz Partners Inc.	20-12-16
Immuno-Biological Laboratories Co., Ltd. announced that it expects to receive ¥1.39 billion in funding from Whiz Partners Inc.	01-12-16
CURED Co., Ltd. announced that it has received ¥159.6 million in funding from Trans Genic Inc., Immuno-Biological Laboratories Co., Ltd.	11-05-16
CURED announced that it expects to receive ¥159.6 million in funding from Trans Genic Inc. and Immuno-Biological Laboratories Co., Ltd.	20-04-16
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it has received ¥100 million in funding from Trans Genic Inc., Immuno-Biological Laboratories Co., Ltd.	31-03-16
Hideki Egawa cancelled the acquisition of 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others.	27-03-16
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it expects to receive ¥100 million in funding from Trans Genic Inc., Immuno-Biological Laboratories Co., Ltd.	24-03-16
Immuno-Biological Laboratories Co., Ltd. announced that it has received ¥406.31 million in funding from Trans Genic Inc., Merrill Lynch Japan Securities Co., Ltd., Investment Arm.	01-03-16
Immuno-Biological Laboratories Co., Ltd. announced that it expects to receive ¥406.31 million in funding from Trans Genic Inc., Merrill Lynch Japan Securities Co., Ltd., Investment Arm.	12-02-16
Hideki Egawa signed a contract to acquire 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others for ¥20.6 million.	27-03-15
Xseed High Growth I managed by Japan Asia Investment Co. Ltd. acquired Skylight Biotech Inc.	31-12-14
Astellas Pharma and Immuno-Biological Conclude Collaborative Research Agreement	31-12-13

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Immuno-Biological Laboratories Co., Ltd.

Aandelen

4570

JP3921300004

Andere talen

Filters